Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
about
A Review: Proteomics in Nasopharyngeal CarcinomaMechanisms of cryoablation: clinical consequences on malignant tumors.Radiotherapy combined docetaxel and oxaliplatin chemotherapy is effective in patients with locally advanced nasopharyngeal carcinoma.Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.Effectiveness and toxicities of intensity-modulated radiation therapy for patients with T4 nasopharyngeal carcinoma.Phase II trial of concurrent chemoradiotherapy with S-1 versus weekly cisplatin for locoregionally advanced nasopharyngeal carcinoma.Identification of CALM as the potential serum biomarker for predicting the recurrence of nasopharyngeal carcinoma using a mass spectrometry-based comparative proteomic approach.Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3-4 nasopharyngeal carcinomaEffects of dosimetric inadequacy on local control and toxicities in the patients with T4 nasopharyngeal carcinoma extending into the intracranial space and treated with intensity-modulated radiotherapy plus chemotherapy.Neoadjuvant chemotherapy with different dose regimens of docetaxel, cisplatin and fluorouracil (TPF) for locoregionally advanced nasopharyngeal carcinoma: a retrospective study.Norcantharidin induce apoptosis in human nasopharyngeal carcinoma through caspase and mitochondrial pathway.Defeating Cancers' Adaptive Defensive Strategies Using Thermal Therapies: Examining Cancer's Therapeutic Resistance, Ablative, and Computational Modeling Strategies as a means for Improving Therapeutic Outcome.Impact of minimum point dose on local control and toxicity in T3-4 nasopharyngeal carcinoma treated with intensity-modulated radiation therapy plus chemotherapy.
P2860
Q26800017-D00BA9C1-DB90-4442-BAF0-374EBCB2208BQ30419671-908BB448-E130-4B04-A348-9893259E35C6Q33426763-96D47F35-3DE6-4A58-A775-A65666DB4908Q33428012-7EACA41B-4967-4063-80AF-7938B7DE1193Q35114677-34CDECC0-61D5-4A79-BF26-10A67E8CB138Q35753624-4FB7C966-A918-4FFA-86EC-E4A8C347547DQ38604563-5C760502-0282-44DC-BCAE-0F042D5F56D0Q40983645-C18A1037-CBB9-4E49-8C56-8DC6654C0878Q41695908-0A9B054B-88CA-4772-8755-3AEB442C23D0Q47142016-20CBE4F1-3A18-49AD-AB52-3555B6D25EB4Q47343333-0A83C9FB-9259-4DF8-AF40-4292137F8279Q51556518-9830D02D-AF58-482C-80F6-6A747BD12C60Q52732435-9E85144D-C3AF-4233-9C20-9230E3E30112
P2860
Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Experience with combination of ...... nced nasopharyngeal carcinoma.
@en
Experience with combination of ...... nced nasopharyngeal carcinoma.
@nl
type
label
Experience with combination of ...... nced nasopharyngeal carcinoma.
@en
Experience with combination of ...... nced nasopharyngeal carcinoma.
@nl
prefLabel
Experience with combination of ...... nced nasopharyngeal carcinoma.
@en
Experience with combination of ...... nced nasopharyngeal carcinoma.
@nl
P2093
P2860
P1476
Experience with combination of ...... nced nasopharyngeal carcinoma.
@en
P2093
Chengrun Du
Hongmei Ying
Junjun Zhou
Youwang Zhang
P2860
P2888
P304
P356
10.1007/S10147-012-0403-Y
P50
P577
2012-04-13T00:00:00Z